Report Overview:
Animal Healthcare refer to the products, which are specially used to prevent and treat animal diseases and ensure animal health, including animal pharmaceuticals and animal vaccines without animal diagnose.
In our report, for vaccine, one unit is 1000 doses.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Healthcare. This report contains market size and forecasts of Companion Animal Healthcare in global, including the following market information:
Global Companion Animal Healthcare Market Revenue, 2018-2024, 2024-2030, ($ millions)
Global top five companies in 2024 (%)
Market Value:
The global Companion Animal Healthcare market was valued at US$ 12300 million in 2024 and is projected to reach US$ 16672 million by 2030, at a CAGR of 5.2% during the forecast period. CAGR of 5.2% (2025 – 2032)
By Types:
• Diagnostics • Therapeutics
By Applications:
Animal Hospital
Animal Clinic
Veterinary Station
Key players include:
• Bayer AG
• Merck and Co., Inc
• Elanco
• Zoetis Inc
• Vetoquinol SA
• Virbac
• Ceva
• Including or Excluding key companies relevant to your analysis.
